Journals / Klimik Dergisi / 2011 / Cilt: 24 - Sayı: 1

Acinetobacter baumannii : A rare cause of meningoencephalitis in a patient on peritoneal dialysis

Acinetobacter baumannii : Periton diyalizi programındaki hastada nadir bir meningoensefalit etkeni

Pages
65–67
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Following the growth of A. baumannii in CSF culture, meropenem treatment provided a complete cure.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Multiple drug resistant Acinetobacter spp. are usually responsible for hospital-acquired infections.
📊
Key Findings & Data:We report a case of meningoencephalitis caused by A. baumannii in a diabetic 36-year-old man on continuous ambulatory peritoneal dialysis.
💡
Conclusion & Impact:Following the growth of A. baumannii in CSF culture, meropenem treatment provided a complete cure.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Multiple drug resistant Acinetobacter spp. are usually responsible for hospital-acquired infections. Development of a central nervous system infection due to Acinetobacter spp. without head trauma or neurosurgical procedure is rare. We report a case of meningoencephalitis caused by A. baumannii in a diabetic 36-year-old man on continuous ambulatory peritoneal dialysis. He was admitted to hospital because of sudden loss of consciousness and jaw tightening, and his physical examination revealed high fever and nuchal rigidity. Laboratory investigations showed elevated acute phase reactants, in addition to normal cranial computed tomographic and electroencephalographic findings. Cerebrospinal fluid (CSF) examination disclosed an elevated protein concentration and very low glucose level. Following the growth of A. baumannii in CSF culture, meropenem treatment provided a complete cure.

Özet

Antimikrobik ajanlara karşı çoğul direnç gösteren Acinetobacter türleri, genellikle hastane kökenli infeksiyonlardan sorumlu olurlar. Bir kafa travması ya da nöroşirürjikal bir işlem olmaksızın Acinetobacter türlerine bağlı bir merkezi sinir sistemi (MSS) infeksiyonu gelişmesi çok nadirdir. Bu yazıda sürekli ayaktan periton diyalizi uygulanan 36 yaşındaki diyabetik erkek hastada ortaya çıkan bir A. baumannii meningoensefaliti olgusu sunuldu. Ani başlayan bilinç kaybı ve çenesinde kilitlenme nedeniyle getirilen hastada yüksek ateş ve ense sertliği saptandı. Akut faz göstergeleri yüksek olan hastanın kraniyal bilgisayarlı tomografisi ve elektroensefalografisi normaldi. Beyin-omurilik sıvısı (BOS)nda protein konsantrasyonu yüksek, glikoz düzeyi ise çok düşük olarak saptandı. BOS kültüründe A. baumannii üremesi üzerine meropenem tedavisi başlanarak tam şifa elde edildi.

🔖

Cite This Article

AYDIN, Z., TAYFUR, F., BATU, A., BİLİR, Y., GÜRSU, M., ÖzTÜRK, S., PEHLİVANOĞLU, F. (2022). Acinetobacter baumannii : A rare cause of meningoencephalitis in a patient on peritoneal dialysis. Klimik Dergisi, Cilt: 24 - Sayı: 1, 65–67. https://ajindex.com/articles/573676

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Jellison TK, McKinnon PS, Rybak MJ. Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam. Pharmacotherapy. 2001; 21(2): 142-8. [Crossref] 2.Metan G, Alp E, Aygen B, Sumerkan B. Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance. J Antimicrob Chemother. 2007; 60(1): 197-9. [Crossref] 3.Cisneros JM, Rodríguez-Baño J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect. 2002; 8(11): 687-93. [Crossref] 4.Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3): 538-82. [Crossref] 5.Geyik MF. Kronik böbrek yetmezliği hastalarında immunizasyon. Türkiye Klinikleri Enfeksiyon Hastalıkları Özel Dergisi. 2008; 1(1): 60-4. 7.Saltoğlu N. Acinetobacter baumannii infeksiyonları ve tedavisi. Klimik Derg. 2007; 20(Suppl. 1): 204-7. 8.Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis.2008; 46(8): 1254-63. [Crossref] 9.Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis.2006; 43(Suppl 2): 49-56. [Crossref] 10.Krol V, Hamid NS, Cunha BA. Neurosurgically related nosocomial Acinetobacter baumannii meningitis: report of two cases and literature review. J Hosp Infect. 2009; 71(2): 176-80. [Crossref]